Beta-hemolytic group a streptococcal orthopaedic infections: Our institutional experience and review of the literature

Priya Nori, Naiha Nadeem, Nidhi Saraiya, Wendy Szymczak, Carmel Boland-Reardon, Mani Kahn

Research output: Contribution to journalReview article

Abstract

Group A streptococcal (GAS) infections have high morbidity and mortality due to toxin production and tissue invasion. We reviewed all orthopaedic GAS infections at our medical centre between January 2017 and April 2019. Median age was 56 years. At least 60% had a body mass index (BMI) of ≥30 kg/m2. Median Charlson comorbidity score was 3 (range 0–7). Clinical cure at 90 days was achieved in only 62%. All 4 patients with underlying orthopaedic hardware were cured. Toxin-neutralizing antibiotics and intravenous immunoglobulin were underutilized. Our review confirms poor outcomes from GAS orthopaedic infections without optimal management.

Original languageEnglish (US)
Pages (from-to)150-154
Number of pages5
JournalJournal of Orthopaedics
Volume21
DOIs
StatePublished - Sep 1 2020

Keywords

  • Group A streptococci (GAS)
  • Hardware infection
  • Necrotizing fasciitis
  • Osteomyelitis
  • Streptococcus pyogenes

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Beta-hemolytic group a streptococcal orthopaedic infections: Our institutional experience and review of the literature'. Together they form a unique fingerprint.

  • Cite this